Birla Fertility & IVF has further solidified its position in India's rapidly growing IVF industry by acquiring BabyScience IVF Clinics, a move that expands its reach to 50 clinics nationwide. The acquisition, announced by company founder Avanti Birla, marks the second major deal for Birla Fertility & IVF in just three months and strengthens its presence in the western and southern regions of India.

Strategic Expansion in Key Regions

The acquisition of BabyScience IVF Clinics brings Birla Fertility & IVF into three new states, with BabyScience currently operating 12 clinics in cities like Mumbai, Bengaluru, and Chennai, and across states including Maharashtra, Karnataka, Tamil Nadu, Delhi, and Haryana. By leveraging BabyScience's established presence in these regions, Birla Fertility & IVF aims to enhance its service offerings and further penetrate the western part of India, while also looking to expand into the northeastern states and overseas markets in the near future.

"We will continue to look for opportunities in west and northeast India, and overseas as we aim for 100 clinics by FY28," said Avanti Birla, noting that global expansion could be on the horizon within the next year.

Rising Demand for IVF Services in India

India's IVF industry is poised for significant growth, driven by a combination of rising infertility rates and a booming medical tourism sector. According to industry analysts, approximately 25-30 million couples in India are currently struggling with infertility issues, creating a substantial market for fertility services. Ernst & Young projects India's IVF market to grow from $793 million in 2020 to $1.45 billion by 2027, with a compound annual growth rate (CAGR) of 15-20%. Custom Market Insights estimates the industry will surpass $5.05 billion by 2033, growing at a CAGR of 16.23%.

Recognizing this opportunity, Birla Fertility & IVF has been actively expanding its footprint. In May, the company acquired an 86% stake in ARMC IVF, a chain of fertility centers in Kerala, adding seven clinics to its portfolio. This deal, estimated at approximately ₹100 crore, marked a significant step in Birla Fertility's expansion strategy.

Also Read : NMDC’s Strategic Delegation of Powers Accelerates Infrastructure Growth Under NMDC 2.0 Vision

₹500-Crore Investment and Future Goals

To achieve its ambitious goal of 100 clinics by FY28, Birla Fertility & IVF plans to invest over ₹500 crore. This expansion will be driven by a combination of organic growth, inorganic acquisitions, and strategic partnerships. While India remains the primary focus for the next 15 months, the company is also exploring opportunities to expand internationally, particularly in Southeast Asia and the Middle East.

"With this acquisition, Birla Fertility & IVF has a combined experience of over 120,000 IVF cycles and has treated more than 230,000 patients," the company stated, highlighting its extensive experience and commitment to providing quality fertility services.

Conclusion

The acquisition of BabyScience IVF Clinics is a strategic move that aligns with Birla Fertility & IVF's long-term vision of becoming a leading player in India's fertility services market. With plans to expand to 100 clinics by FY28 and a potential global expansion on the horizon, the company is well-positioned to capitalize on the growing demand for IVF services in India and beyond. As the IVF market continues to evolve, Birla Fertility & IVF's strategic acquisitions and robust growth plans will likely play a pivotal role in shaping the future of fertility treatment in India.

Check latest IPO Review & analysis, Live GMP today, Live Subscription Status Today, Share Price, Financial Information, latest IPO news, Upcoming IPO News before applying in the IPO. The Upcoming IPOs in this week and coming weeks are Brace Port Logistics Limited, Forcas Studio Limited, Interarch Building Products Limited. The current active IPO is Broach Lifecare (Maple) Hospital Limited, Solve Plastic Products Limited

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst & Finance Saathi Telegram Channel for Regular Share Market, News & IPO Updates

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX & Upstox.